ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,595, issued on Aug. 5, was assigned to INIVATA LTD (Cambridge, Great Britain).
"Method for the analysis of minimal residual disease" was invented by Vincent Plagnol (Cambridge, Great Britain), Tim Forshew (Stevenage, Great Britain), Samuel Woodhouse (Cambridge, Great Britain), Andrew Lawson (Waltham Cross, Great Britain) and Matthew Smith (Cambridge, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is a method for the analysis of minimal residual disease, the method comprising obtaining multiple pairs of primers, performing a targeted multiplex amplification using the multiple pairs of primers to produce amplicons, sequenc...